This miRNA enhances IL-10 secretion in gastric cancer cells by targeting the RB1/NF-κBp65 pathway, thereby facilitating Treg differentiation, regulating EMT, and remodeling the tumor immune microenvironment (129). This evidence concerns the gene IL10 and neoplasm.